Foundations

Xanthelasma is not a pigment target

Dr Ong Jin Khang · 10 Sep 2026 · 中文版

A xanthelasma is a soft yellow deposit of fat, mostly cholesterol, sitting in the skin of the eyelid. Dr Ong Jin Khang of The Retreat Clinic in Setia Alam writes this because the lesion is routinely brought in as a pigment problem. There is no melanin in it, so a pigment laser has nothing to absorb into, and the eyelid is a poor place to discover that by trying. This clinic does not remove xanthelasma. What follows is what the deposit is, who assesses it, and the blood test worth having whatever gets decided about the skin.

A folded pathology request form and a pen on a plain wooden desk in morning daylight, nothing clinical in frame, no patient and no face visible

The skin comes off the lid and the metabolism carries on exactly as it was.

What the yellow actually is

A xanthoma is a skin lesion caused by fat accumulating inside macrophages in the skin. Xanthelasma is the commonest form, and it has habits. It appears near the inner corner of the upper eyelid, often symmetrically across upper and lower lids, and starts as a small bump that enlarges slowly over months. The deposits are lipid-rich, cholesterol in particular, which is where the colour comes from.

That description is doing more work than it looks. A mark that arrived slowly, sits in a predictable place, feels soft rather than firm, and is yellow rather than brown is behaving like a lipid deposit and not like sun damage. Brown marks are a category rather than one thing, and the diagnosis decides the tool in exactly the same way here.

Why a pigment laser has nothing to hold on to

Dermatological lasers work by matching a wavelength to a chromophore, the substance in the target that absorbs that light. Pigmented lesions contain melanin, which absorbs broadly across the visible and infrared wavebands, and the quality-switched systems are built for it. Vascular lesions contain oxygenated haemoglobin, which strongly absorbs visible light at 418, 542 and 577 nm. Infrared lasers such as CO2 and erbium:YAG are absorbed by water. The aim each time is to destroy the target and spare what surrounds it.

Now read the lesion back against that list. A xanthelasma is fat inside macrophages in the skin. There is no melanin in it, and a device chosen for melanin is pointed at a substance that is not present. This is the same rule that governs every mark near the eye here, set out in the piece on why a lesion on the eyelid is not a pigment target.

The treatment literature reflects it without arguing about it. The approaches described with usable results are ablative lasers, CO2 and erbium:YAG, which work through water, together with topical trichloroacetic acid and surgical excision. Depth decides between them: fractionated erbium:YAG or CO2 for superficial deposits, trichloroacetic acid at intermediate depth, excision for larger ones. None is a melanin device, and none is a choice to be made from a photograph.

Treatment on an eyelid has eyelid consequences

The reported complications are specific to where this lesion lives. Scarring and ectropion, meaning the lid turning outward away from the eye, are described where trichloroacetic acid is applied near the lid. With trichloroacetic acid the review figures run to hypopigmentation in roughly a fifth to a third of patients and hyperpigmentation in around one in ten. With radiofrequency ablation the same review reports scarring in 40% and pigmentary problems in 45%, against lower figures for trichloroacetic acid in the same comparison.

Those are eyelid outcomes rather than skin outcomes, and they are why this belongs to someone whose subject is the eyelid rather than the face around it. An oculoplastic surgeon is an ophthalmologist with further training in the lids, the tear system and the socket. Dr Catherine Chow, a consultant oculoplastic surgeon and a colleague I have published with on periocular injection, keeps a hub on what an eyelid can develop and what each finding needs, which is a fuller account of that ground than a skin clinic should be giving.

It comes back, and the rate depends on what was done

Recurrence is part of the honest version of this conversation. Across modalities it generally sits under half of cases and varies by method, rises to around 60% after a repeat treatment, and deeper deposits recur considerably more. After topical trichloroacetic acid the reported range is 25 to 39%. Involvement of both upper and lower lids raises it further.

A patient given those numbers in advance makes a different decision from a patient given them afterwards. That is the entire reason to print them.

The blood test conversation, and the half people get wrong

Roughly half of adults with xanthelasma have abnormal lipid levels, with associations including inherited dyslipidaemia, diabetes and thyroid dysfunction. The other half do not, and the dermatology reference says so plainly: xanthelasma will often occur with normal levels of circulating lipids. Both halves belong in the same breath. A yellow plaque does not diagnose high cholesterol, and a normal cholesterol result does not make the plaque meaningless.

The investigations described are a serum lipid profile, taken after a twelve hour fast, along with liver, thyroid and renal function tests and a fasting glucose. The listed associations run from familial hypercholesterolaemia and type II hyperlipoproteinaemia to primary biliary cirrhosis. That panel is ordered and interpreted by the reader's own doctor. It is not a skin clinic's to read, and I will not be reading anybody's.

There is a reason to bother even where the numbers come back ordinary. A 2013 study found dyslipidaemia in 60% of the twenty cases where a lipid profile was available, a small denominator that should be read as one, and its authors recommend a determined effort to rule out prediabetes, prehypertension and dyslipidaemia in such patients at the earliest opportunity. A 2018 treatment review reports that xanthelasma palpebrarum appeared to be a predictor of risk for myocardial infarction, ischaemic heart disease and severe atherosclerosis, and that presentation before the age of 40 should prompt screening for inherited lipid disorders.

Removing the plaque does nothing to any of that. The skin comes off the lid and the metabolism carries on exactly as it was.

Why this one leaves the room

The Retreat Clinic does not remove xanthelasma, does not operate on eyelids, and does not interpret a lipid result. That is three refusals in one sentence, and each has a different reason behind it.

There is a fourth, and it matters more than the other three. No source I can find supports telling a xanthelasma apart from something else on an eyelid by appearance alone, and the eyelid is a thin, mobile piece of skin sitting directly in front of an eye. A yellow patch that has been there unchanged for two years is probably what it looks like. The way to know is for somebody who assesses eyelids to look at it, which is why Dr Chow has written on the eyelid skin changes that are not normal ageing, and why a short list of findings around the eye ends a consultation here rather than starting a treatment plan.

The instinct with a yellow mark on a lid is to ask what will remove it. The more useful first question is what put it there, and that one is answered with a blood sample and an eyelid examination rather than with a machine.

Common questions

Can a pigment laser remove xanthelasma?

It is the wrong instrument for the target. Pigment lasers are built around melanin, which absorbs their wavelength strongly. A xanthelasma is fat sitting inside cells in the skin and contains no melanin, so the energy has nothing to land in. The approaches described in the treatment literature with usable results are ablative lasers such as CO2 and erbium:YAG, which work through water, topical trichloroacetic acid, and surgical excision, chosen according to how deep the deposit sits.

Does xanthelasma mean my cholesterol is high?

Sometimes, and the honest answer has two halves. Roughly half of adults with xanthelasma have abnormal lipid levels, with associations including inherited dyslipidaemia, diabetes and thyroid dysfunction. The other half do not, and dermatology references state directly that xanthelasma often occurs with normal levels of circulating lipids. A yellow plaque does not diagnose high cholesterol, and a normal result does not make the plaque meaningless. The panel is still worth having, ordered by your own doctor.

Does The Retreat Clinic remove xanthelasma?

No. This clinic does not remove xanthelasma, does not operate on eyelids, and does not interpret a lipid result. The lesion sits on a thin, mobile piece of skin directly in front of an eye, and it belongs with a doctor whose assessment includes how the lid works, not only how the skin looks.

Does xanthelasma come back after it is removed?

Often enough that it should be said before a decision rather than after one. Recurrence across modalities generally sits under half of cases and varies by method, rises to around 60% after a repeat treatment, and is considerably higher for deeper deposits. After topical trichloroacetic acid the reported range is 25 to 39%. Involvement of both the upper and lower lids raises the rate further.

Which blood tests are usually done for xanthelasma?

The investigations described are a serum lipid profile, taken after a twelve hour fast, along with liver, thyroid and renal function tests and a fasting blood glucose. The associations listed run from familial hypercholesterolaemia and type II hyperlipoproteinaemia to primary biliary cirrhosis. Which of those apply, and what any result means, is a conversation with your own doctor rather than with a skin clinic.

Who should look at a yellow patch on the eyelid?

A doctor who assesses eyelids. For the lid itself that is an oculoplastic surgeon, an ophthalmologist with further training in the lids, the tear system and the socket behind the eye. No source supports telling a xanthelasma apart from anything else on a lid by appearance alone, which is the whole reason the looking is delegated rather than done from a photograph.

See also